These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 10602893

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. CD34+ stem cells in chronic myeloproliferative disorders.
    Thiele J, Kvasnicka HM.
    Histol Histopathol; 2002 Apr; 17(2):507-21. PubMed ID: 11962756
    [Abstract] [Full Text] [Related]

  • 25. The frequency and significance of megakaryocytic emperipolesis in myeloproliferative and reactive states.
    Cashell AW, Buss DH.
    Ann Hematol; 1992 Jun; 64(6):273-6. PubMed ID: 1637881
    [Abstract] [Full Text] [Related]

  • 26. Value of bone marrow biopsy in the diagnosis of essential thrombocythemia.
    Florena AM, Tripodo C, Iannitto E, Porcasi R, Ingrao S, Franco V.
    Haematologica; 2004 Aug; 89(8):911-9. PubMed ID: 15339673
    [Abstract] [Full Text] [Related]

  • 27. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
    Bock O, Loch G, Schade U, von Wasielewski R, Schlué J, Kreipe H.
    J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
    [Abstract] [Full Text] [Related]

  • 28. Modern diagnostics in chronic myeloproliferative diseases (CMPDs).
    Haferlach T, Kern W, Schnittger S, Schoch C.
    Ann Hematol; 2004 Apr; 83 Suppl 1():S59-61. PubMed ID: 15124674
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF) - a clinicopathological study.
    Thiele J, Kvasnicka HM, Boeltken B, Zankovich R, Diehl V, Fischer R.
    Leukemia; 1999 Nov; 13(11):1741-8. PubMed ID: 10557047
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression.
    Panteli K, Zagorianakou N, Bai M, Katsaraki A, Agnantis NJ, Bourantas K.
    Eur J Haematol; 2004 Jun; 72(6):410-5. PubMed ID: 15128419
    [Abstract] [Full Text] [Related]

  • 35. Chronic myeloproliferative disorders in bone marrow biopsies.
    Georgii A, Vykoupil KF, Buhr T, Choritz H, Döhler U, Kaloutsi V, Werner M.
    Pathol Res Pract; 1990 Feb; 186(1):3-27. PubMed ID: 2179909
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Chronic myeloproliferative disorders.
    Spivak JL, Barosi G, Tognoni G, Barbui T, Finazzi G, Marchioli R, Marchetti M.
    Hematology Am Soc Hematol Educ Program; 2003 Feb; ():200-24. PubMed ID: 14633783
    [Abstract] [Full Text] [Related]

  • 38. Abnormalities of megakaryocytes in myelitis and chronic myeloproliferative diseases.
    Thiele J, Holgado S, Choritz H, Georgii A.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1982 Feb; 41(1-2):67-81. PubMed ID: 6134385
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Classification of Ph-negative chronic myeloproliferative disorders--morphology as the yardstick of classification.
    Kvasnicka HM, Thiele J.
    Pathobiology; 2007 Feb; 74(2):63-71. PubMed ID: 17587877
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.